<< Back to News

Webinar:First-line Treatment Options for Metastatic Non–Small Cell Lung Cancer (NSCLC)

Merck is sponsoring an interactive live webcast entitled: First-line Treatment Options for Metastatic Non–Small Cell Lung Cancer (NSCLC) 

Learning Objectives 

  •  Understand the clinical data associated with the first-line treatment options for metastatic NSCLC 
  •  Identify the appropriate patient with metastatic NSCLC eligible for first-line treatment option 

Click Here to read the Webcast invitation and for directions on registering for the event.